Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
The goal of this clinical trial is to determine if treatment of patients with two doses of ketamine plus levetiracetam versus levetiracetam alone leads to more effective control of status epilepticus.
- Status
- recruiting
- Phase
- Phase 3
- Institution
- University of Virginia
- Principal investigator
- Jaideep Kapur, MD, PhD
- Start date
- 2026-03-06
- End date
- 2029-12-01
- Registry ID
- NCT06907173
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.